Evidence map›Paper›PMID 36140225›Full record

ReviewBiomedicines2022

Enhancement of Nitric Oxide Bioavailability by Modulation of Cutaneous Nitric Oxide Stores.

Christoph V Suschek, Dennis Feibel, Maria von Kohout, Christian Opländer

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Dual-layer microneedles with NO/OBioactive materials · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christoph V SuschekDepartment for Orthopedics and Trauma Surgery, Medical Faculty, Heinrich-Heine-University Dusseldorf, 40225 Düsseldorf, Germany.
Dennis FeibelDepartment for Orthopedics and Trauma Surgery, Medical Faculty, Heinrich-Heine-University Dusseldorf, 40225 Düsseldorf, Germany.
Maria von KohoutPlastic Surgery, Hand Surgery, Burn Center, Cologne-Merheim Hospital, 51109 Cologne, Germany.
Christian OpländerInstitute for Research in Operative Medicine (IFOM), University Witten/Herdecke, 51109 Cologne, Germany.
Heinrich Heine University Düsseldorf · DE

Funding

Deutsche Forschungsgemeinschaft OP 207/11-1Internal grant program Faculty of Health at Witten/Herdecke University, Germany IFF 2022-18
6 · The paper itself

Abstract

The generation of nitric oxide (NO) in the skin plays a critical role in wound healing and the response to several stimuli, such as UV exposure, heat, infection, and inflammation. Furthermore, in the human body, NO is involved in vascular homeostasis and the regulation of blood pressure. Physiologically, a family of enzymes termed nitric oxide synthases (NOS) generates NO. In addition, there are many methods of non-enzymatic/NOS-independent NO generation, e.g., the reduction of NO derivates (NODs) such as nitrite, nitrate, and nitrosylated proteins under certain conditions. The skin is the largest and heaviest human organ and contains a comparatively high concentration of these NODs; therefore, it represents a promising target for many therapeutic strategies for NO-dependent pathological conditions. In this review, we give an overview of how the cutaneous NOD stores can be targeted and modulated, leading to a further accumulation of NO-related compounds and/or the local and systemic release of bioactive NO, and eventually, NO-related physiological effects with a potential therapeutical use for diseases such as hypertension, disturbed microcirculation, impaired wound healing, and skin infections.

Indexed as

cold atmospheric plasmamicrocirculationnitric oxide donornitriteskinUVAwound healing

Identifiers

PMID36140225
PMCPMC9496039
OpenAlexW4293526637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.